Disproportionality analysis of vibegron-associated adverse events using the FDA adverse event reporting system (FAERS): a real-world pharmacovigilance study

Disproportionality analysis of vibegron-associated adverse events using the FDA adverse event reporting system (FAERS): a real-world pharmacovigilance study

Abstract Background Overactive bladder (OAB) syndrome has a significant impact on quality of life, and vibegron has emerged as a therapeutic option. This study aims to evaluate the safety profile of vibegron in a disproportionality analysis by analyzing adverse event (AE) reports from the Food and D...

Full description

Saved in:
Bibliographic Details
Main Authors: Bangbei Wan, Zhi Zhou, Ning Ma, Weiying Lu
Format: Article
Language:English
Published: BMC 2025-02-01
Series:European Journal of Medical Research
Subjects:
Overactive bladder syndrome
Vibegron
FAERS database
Adverse event
System organ class
Online Access:https://doi.org/10.1186/s40001-025-02406-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40001-025-02406-9

Similar Items